CPA
ABBV icon

Columbia Pacific Advisors’s AbbVie ABBV Stock Holding History

Columbia Pacific Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-374,000
Closed -$23.4M – 42
2016
Q4 		$23.4M Hold
374,000
– – 13.14% 2
2016
Q3 		$23.6M Hold
374,000
– – 14.81% 2
2016
Q2 		$23.2M Buy
+374,000
New +$22.8M 14.12% 2

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Columbia Pacific Advisors's ABBV Position: Q1 2017 in Review

Columbia Pacific Advisors sold out of AbbVie (ABBV) in Q1 2017, closing a stake of 374,552 shares — an estimated $23.5M sold.

Columbia Pacific Advisors first reported a position in ABBV in Q2 2016 and held it in 3 quarters. The position peaked at $23.6M in Q3 2016. 1,727 funds tracked by Wall St. Rank hold ABBV as of Q1 2017.

  • Columbia Pacific Advisors reported no remaining AbbVie position as of Q1 2017 after selling out during the quarter.
  • Columbia Pacific Advisors sold 374,552 AbbVie shares in Q1 2017, an estimated $23.5M.
  • Columbia Pacific Advisors first reported a position in AbbVie in Q2 2016 and held it in 3 quarters.
  • Columbia Pacific Advisors's AbbVie position peaked at $23.6M in Q3 2016.
  • 1,727 funds tracked by Wall St. Rank held AbbVie as of Q1 2017.

Based on Columbia Pacific Advisors's 13F filing for Q1 2017, filed 15 May 2017.